PBGM01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PBGM01, covering 2025-05-21 to 2025-05-21. Get the full timeline:
Most recent: Clinical Trial Update: Study of Safety, Tolerability and Efficacy of PBGM01 in Pediatric Participants With GM1 Gangliosidosis [Phase 1, Phase 2]